DOI:
10.1055/s-00000137
Krankenhaushygiene up2date
LinksClose Window
References
Desai A, Kovanda L, Kowalski D. et al.
Population pharmacokinetics of isavuconazole from phase 1 and phase 3 (SECURE) trials in adults and target attainment in patients with invasive infections due to Aspergillus and other filamentous fungi.
Antimicrob Agents Chemother 2016;
60: 5483-5491
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.